Company TCR2 Therapeutics Inc.
Equities
TCRR
US87808K1060
Biotechnology & Medical Research
Business Summary
Number of employees: 58
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Bertrand
PSD | President | 59 | 23-05-31 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Praveen Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Peter Olagunju
COO | Chief Operating Officer | - | 21-07-19 |
Carl F. Mauch
IRC | Investor Relations Contact | - | - |
Kevin Zikaras
PRN | Corporate Officer/Principal | - | 18-05-31 |
Richard Roomberg
AUD | Comptroller/Controller/Auditor | - | 18-12-31 |
Margaret Siegel
LAW | General Counsel | - | 17-12-31 |
Corporate Officer/Principal | 41 | 21-12-31 | |
Viera Muzithras
LAW | General Counsel | - | 20-05-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,261,745 | 38,342,495 ( 97.66 %) | 0 | 97.66 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |